Mentari Therapeutics Inc. Company Profile
NASDAQ: MTRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Mentari Therapeutics at a glance
Mentari Therapeutics Inc. (NASDAQ: MTRI) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Sacramento, CA, Canada. Mentari Therapeutics is led by Mr. Gregory J. Divis Jr.. At a market capitalization of $856.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001728328, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Mentari Therapeutics do?
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.
Business description based on the company's public filings.
Company information
- Legal name
- Mentari Therapeutics Inc.
- Ticker
- NASDAQ: MTRI
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Gregory J. Divis Jr.
- Headquarters
- 1625 North Market Blvd., Sacramento, CA, Canada
- Phone
- (916) 445-1254
- Website
- mentaritx.com
- Market cap
- $856.94M
- SEC CIK
- 0001728328
- Latest annual report
- 10-K · Sep 9, 2026
Companies similar to Mentari Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LTGOLatigo Biotherapeutics Inc. | 13.00 | -1.81% | $861.89M | vs MTRI |
| PHARPharming Group N.V. ADS | 11.54 | -5.10% | $816.78M | vs MTRI |
| CRVSCorvus Pharmaceuticals Inc. | 9.67 | -3.40% | $815.69M | vs MTRI |
| AKTSAktis Oncology Inc. | 16.15 | -1.52% | $901.14M | vs MTRI |
| VSTMVerastem Inc. | 6.33 | -7.73% | $797.67M | vs MTRI |
| SNDXSyndax Pharmaceuticals Inc. | 8.72 | -4.49% | $785.05M | vs MTRI |
| IRWDIronwood Pharmaceuticals Inc. Class A | 4.70 | -0.21% | $778.09M | vs MTRI |
| SVRASavara Inc. | 4.26 | -18.23% | $939.86M | vs MTRI |